Advertisement

Biotechnology in blood transfusion

Proceedings of the Twelfth Annual Symposium on Blood Transfusion, Groningen 1987, organized by the Red Cross Blood Bank Groningen-Drenthe

  • C. Th. Smit Sibinga
  • P. C. Das
  • L. R. Overby

Part of the Developments in Hematology and Immunology book series (DIHI, volume 21)

Table of contents

  1. Front Matter
    Pages I-XII
  2. Fundamentals of biotechnology

    1. Front Matter
      Pages XIII-XIII
    2. S. L. Holbeck, G. T. Nepom
      Pages 33-36
    3. Back Matter
      Pages 47-51
  3. Laboratory application of biotechnology

  4. Biotechnology and blood components

    1. Front Matter
      Pages N3-N3
    2. Ch. R. Bennett Jr.
      Pages 139-147
    3. L. F. M. H. de Leij, M. Elias, A. G. ter Haar, C. Th. Smit Sibinga, T. The
      Pages 161-173
    4. J. D. Lutton, R. D. Levere, N. G. Abraham
      Pages 175-210
    5. Back Matter
      Pages 211-216
  5. Clinical application and future directions

    1. Front Matter
      Pages N4-N4
    2. E. Briët, A. H. J. T. Bröcker-Vriends
      Pages 217-222
    3. K. A. High, G. C. White II, C. W. McMillan II, B. G. Macik, H. R. Roberts
      Pages 223-230
    4. Back Matter
      Pages 253-257

About this book

Introduction

This symposium is devoted to Biotechnology in Blood Transfusion; there are 22 experts discussing the state of the art in the application of monoclonal anti­ bodies, recombinant DNA technologies and heterologous expression systems to the improvement and sometimes replacement of blood products, charac­ terization of blood constituents, and the effect of these developments on blood transfusion procedures. Ten and maybe five years ago the title of a symposium such as this would have been Biosciences in blood transfusion, informing what basic developments in molecular biology, biochemistry and human physiology might pertain to blood transfusion in the distant future. That future is getting closer, and not only one is interested in basic developments in immunology, recognition and identification of viral and bacterial components and products, tissue and blood bloodgroup blood group typing, typing, but also in the potential application of these developments and their economic perspectives. That is what biotechnology is all alI about: basic science telIs tells us where and how we might look for new technologies, and the development of such tech­ nologies is only possible if there is a perspective for improvement in quality, safety, acceptance or performance to cost ratio.

Keywords

Antigen Expression HIV biochemistry bioengineering biotechnology blood chemistry genetics lymphocytes molecular genetics physiology preparation transgen transplantation

Editors and affiliations

  • C. Th. Smit Sibinga
    • 1
  • P. C. Das
    • 1
  • L. R. Overby
    • 2
  1. 1.Red Cross Blood Bank Groningen-DrentheThe Netherlands
  2. 2.Chiron CorporationEmmeryvilleUSA

Bibliographic information

Industry Sectors
Pharma
Biotechnology
Consumer Packaged Goods